期刊文献+

高敏肌钙蛋白Ⅰ在不稳定型心绞痛严重程度及预后评估中的应用 被引量:11

Severity and prognosis evaluation of serum high sensitivity cardiac troponin Ⅰ in unstable angina pectoris
下载PDF
导出
摘要 目的探讨高敏肌钙蛋白Ⅰ(hs-cTnⅠ)检测在不稳定型心绞痛(UAP)患者的诊断、冠状动脉病变严重程度及短期预后判断等方面中的应用。方法 102例常规血清cTnⅠ阴性的UAP患者,冠状动脉造影前测定血清hs-cTnI水平,随访30d,记录心血管不良事件。结果 hs-cTnⅠ水平随着冠脉病变的严重程度而升高,hs-cTnⅠ水平越高,冠脉狭窄程度及病变累及血管的程度越严重,差异有统计学意义(P<0.05)。hs-cTnⅠ升高组主要心血管事件发生率明显高于hs-cTnⅠ正常组,差异有统计学意义(P<0.01)。结论 hs-cTnI水平的高低可预测冠脉病变的狭窄严重程度与病变范围,其升高提示短期预后不佳、主要心血管事件发生率增加,可作为UAP早期危险分层的一个指标。 Objective To explore the application of serum high sensitivity cardiac troponin I (hs-cTnI) detection in clinical diag- nosis, coronary artery disease severity and short-term prognostic in unstable angina pectoris(UAP) patients. Methods 102 UAP patients with cTnI negative were selected. Serum bs-cTnI was measured before coronary angiography, and was followed-up to 30 days. The main cardiovascular events was recorded. Results Serum hs-cTnI levels increased with the degree of coronary artery dis- ease. The levels of serum hs-cTnI were higher, coronary stenosis and vascular lesions were more serious(P〈0.05). The incidence of short-term cardiovascular events in patients with elevated serum hs-cTnI was significantly higher than that of normal group(P〈 0.01). Conclusion Serum hs-cTnI levels may predict the severity of coronary and the major cardiovascular events. It may be used as an early risk stratification in UAP.
出处 《国际检验医学杂志》 CAS 2012年第17期2049-2050,2053,共3页 International Journal of Laboratory Medicine
基金 中山市科技计划项目立项课题资助项目(20113A061)
关键词 心绞痛 不稳定型 肌钙蛋白Ⅰ 心血管造影术 预后 angina, unstable troponin I angiocardiographies prognosis
  • 相关文献

参考文献8

  • 1Apple FS,Smith SW,Pearce LA. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presention with symptoms suggestive of acute coronary syndrome[J].Clinical Chemistry,2008,(04):723-728.doi:10.1373/clinchem.2007.097162.
  • 2James S,Armstrong P,Califf R. Troponin T levels and risks of 30-day outcomes in patients with the acute coronary syndrome:prospective verification in the GUSTO-Ⅳ trial[J].American Journal of Medicine,2003,(03):178-184.doi:10.1016/S0002-9343(03)00348-6.
  • 3Apple FS. A new season for cardiac troponin assays:it′s time to keep a scorecard[J].Clinical Chemistry,2009,(07):1303-1307.doi:10.1373/clinchem.2009.128363.
  • 4James S,Flodin M,Johnston N. The antibody configurations of cardiac troponin I assays may determine their clinical performance[J].Clinical Chemistry,2006,(05):832-837.doi:10.1373/clinchem.2005.064857.
  • 5Apple FS,Pearce LA,Smith SW. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events[J].Clinica Chimica Acta,2009,(05):930-937.
  • 6Hjortsh(o)j S,Dethlefsen C,Kristensen SR. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers[J].Scandinavian Journal of Clinical and Laboratory Investigation,2008,(03):130-133.
  • 7Wilson SR,Sabatine MS,Braunwald E. Dectection of myocardial injury in patients with unstable angiana using a novel nanoparticle cardiac troponin I assays:observations from the PROTECT-TIMI 30 Trial[J].American Heart Journal,2009,(03):386-391.doi:10.1016/j.ahj.2009.06.011.
  • 8Morrow DA,Cannon CP,Rifai N. Ability of minor elevations of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction:results from a randomized trial[J].Journal of the American Medical Association,2001,(19):2405-2412.doi:10.1001/jama.286.19.2405.

同被引文献63

  • 1徐彤彤,于方.冠心病患者血清C反应蛋白水平的变化及其临床意义[J].心脏杂志,2004,16(5):443-445. 被引量:7
  • 2陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 4尚红,潘柏中.医学检验项目指南一帮你解析化验结果[M].北京:人民卫生出版社,2011:91.
  • 5Apple FS,Smith SW, Pearce LA, et al. Use of the Centaur TnI- Ultra assay for detection of myocardial infarction and adverse e- vents in patients presenting with symptoms suggestive of acute coronary syndrome [J]. Clin Chem, 2008,54 (4) : 723-728.
  • 6James S,Armstrong P,Califf R,et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial[J]. Am J Med, 2003,115(3) : 178-184.
  • 7Meisinger C ,Doring A,Schneider A,et d.Serum Gamma-glutamyl- transferase is a predictor of incident coronary events in apparently healthy men from the general population [J].Atherosclerosis ,2006, 189(14) :297-302.
  • 8Lee DH,Silventoinen K,Hu G,et aLSerum gamma -glutamyltrans- ferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28838 middle-aged men and women[J].Eur Heart J, 2006,27(18) :2170-2176.
  • 9Willerson JT,Ridker PM.Inflammation as a cardiovascular risk factor [J].Circulation ,2004,109(21 ,Supp 1 ) : lI 2- H 10.
  • 10Lee DH,Blomhoff R,Jacobs DR Jr.Is serum gamma-glutamyltrans- ferase a marker of oxidative stress?[J].Frce Radic Res,2004,38 (6):535-539.

引证文献11

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部